Wear it pink this October At work. At school. At home. Wherever you do it, wear pink and raise money to fund life-changing research and support
Home About us Media Breast Cancer Now media statements 174 results We respond to The NHS Jewish BRCA Testing Programme identifying 235 people with higher risk of cancer 16 Jan 2025 1 min read We respond to NICE’s provisional rejection of capivasertib with fulvestrant for certain types of secondary breast cancer 14 Jan 2025 1 min read We respond to Audit Wales Cancer Services Report 14 Jan 2025 2 min read Responding to the NICE decision to approve olaparib (Lynparza) for certain people with locally advanced or secondary breast cancer who have inherited an altered BRCA gene. 09 Jan 2025 2 min read We respond to new University of Oxford research highlighting the potential of the TriOx test to improve early cancer detection 08 Jan 2025 1 min read Breast Cancer Now responds to early diagnosis in England reaching highest level ever 02 Jan 2025 1 min read Breast Cancer Now 's response to NICE final decision on elacestrant (Korserdu) 19 Dec 2024 1 min read We respond to report revealing more than one in four premature deaths in UK 'will be due to cancer by 2050' 21 Nov 2024 1 min read We respond to NICE guidance to not recommend Enhertu for HER2-low secondary breast cancer remaining unchanged 19 Nov 2024 1 min read We respond to the National Cancer Medicines Advisory Group in Scotland supporting use of anastrozole, tamoxifen and raloxifene to reduce risk of breast cancer 24 Oct 2024 1 min read We respond to new research that suggests women who use a contraceptive coil may have a slightly higher risk of developing breast cancer 17 Oct 2024 1 min read We respond to news that a blood test could detect 12 most common cancers before symptoms develop 08 Oct 2024 2 min read Previous 1 2 ... 15 Next
We respond to The NHS Jewish BRCA Testing Programme identifying 235 people with higher risk of cancer 16 Jan 2025 1 min read
We respond to NICE’s provisional rejection of capivasertib with fulvestrant for certain types of secondary breast cancer 14 Jan 2025 1 min read
Responding to the NICE decision to approve olaparib (Lynparza) for certain people with locally advanced or secondary breast cancer who have inherited an altered BRCA gene. 09 Jan 2025 2 min read
We respond to new University of Oxford research highlighting the potential of the TriOx test to improve early cancer detection 08 Jan 2025 1 min read
Breast Cancer Now responds to early diagnosis in England reaching highest level ever 02 Jan 2025 1 min read
Breast Cancer Now 's response to NICE final decision on elacestrant (Korserdu) 19 Dec 2024 1 min read
We respond to report revealing more than one in four premature deaths in UK 'will be due to cancer by 2050' 21 Nov 2024 1 min read
We respond to NICE guidance to not recommend Enhertu for HER2-low secondary breast cancer remaining unchanged 19 Nov 2024 1 min read
We respond to the National Cancer Medicines Advisory Group in Scotland supporting use of anastrozole, tamoxifen and raloxifene to reduce risk of breast cancer 24 Oct 2024 1 min read
We respond to new research that suggests women who use a contraceptive coil may have a slightly higher risk of developing breast cancer 17 Oct 2024 1 min read
We respond to news that a blood test could detect 12 most common cancers before symptoms develop 08 Oct 2024 2 min read
